Monocyte lymphocyte ratio As a predictor of Diabetic Kidney Injury in type 2 Diabetes mellitus; The MADKID Study
Authors:
- 29 July 2020
- journal article
- research article
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 19 (2) , 997-1002
Abstract
Aims Inflammation is a cardinal pathogenetic mechanism in diabetic kidney injury (DKI). The detection of microalbuminuria (MA) is very important in preventing end-stage renal failure in diabetic subjects. A combination of high monocyte and low lymphocyte counts are used as a marker of inflammation. Monocyte to lymphocyte ratio (MLR) is considered as a marker in inflammatory diseases. We aimed to evaluate the MLR levels in diabetic subjects as a predictive marker in detecting MA. Methods A total of 212 patients with type 2 diabetes mellitus (T2DM) were included in the study. Patients with T2DM were divided into two groups as MA and normoalbuminuria (NA). MLR of the groups were compared. Results There were 72 patients in MA and 140 patients in NA group. MLR of the MA and NA groups were 0.247 (0.131–0.540) and 0.211 (0.052–0.390), respectively (p < 0.001). There was a statistically significant correlation between MLR and MA (r = 0.228, p = 0.001). In multivariate backward logistic regression analysis, MLR, fasting blood glucose, HbA1c and presence of comorbid clinical diseases were determined as independent predictors of DKI. Conclusions We suggest that MLR could serve as a predictive and effective marker for DKI in diabetic subjects due to its strong correlation with MA and inexpensive and readily available nature.Keywords
This publication has 24 references indexed in Scilit:
- Use of the Monocyte-to-Lymphocyte Ratio to Predict Diabetic RetinopathyInternational Journal of Environmental Research and Public Health, 2015
- Monocytosis and a Low Lymphocyte to Monocyte Ratio Are Effective Biomarkers of Ulcerative Colitis Disease ActivityInflammatory Bowel Diseases, 2015
- Lymphocyte-to-monocyte ratio: a novel marker for critical limb ischemia in PAOD patientsInternational Journal Of Clinical Practice, 2014
- Neutrophil–lymphocyte ratio is a reliable predictive marker for early‐stage diabetic nephropathyClinical Endocrinology, 2014
- Prognostic Value of Monocyte Count in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial)The American Journal of Cardiology, 2012
- Inflammation in Diabetic NephropathyMediators of Inflammation, 2012
- Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathyNature Reviews Nephrology, 2011
- Which White Blood Cell Subtypes Predict Increased Cardiovascular Risk?JACC, 2005
- Diabetes and nephropathyCurrent Opinion in Nephrology and Hypertension, 2003
- The Stages in Diabetic Renal Disease: With Emphasis on the Stage of Incipient Diabetic NephropathyDiabetes, 1983